Brief Description
Observational study that is one visit that after the Informed consent is signed, medical history is reviewed, and blood and urine specimens are collected. Optional genetic counseling is offered as well.
Estimated Enrollment
60
Estimated End Date
May 2025
Trial is for people with
18-65 year olds with moderate Proteinuria
Study Goal
To catch more patients of Black, African-American, Afro-Latino decent with kidney disease due to APOL1 Gene.
What is involved for the patient?
Reading and signing of informed consent, review of medical history and medications, and collection of blood and urine samples.
About the drug or intervention
No intervention for this trial, but this is a trial if the patient tests APOL1 positive that they may be referred to